Secondary Logo

Institutional members access full text with Ovid®

Prognosis of Bell Palsy

A Clinical, Neurophysiological, and Ultrasound Study

Zaki, Maha A.*; Elkholy, Saly H.; Abokrysha, Noha T.*; Khalil, Alshaimaa Sobhi; Nawito, Amani M.; Magharef, Nagween W.*; Kishk, Nirmeen A.*

Journal of Clinical Neurophysiology: November 2018 - Volume 35 - Issue 6 - p 468–473
doi: 10.1097/WNP.0000000000000509
Original Research
Buy

Purpose: Bell palsy is the most common cause of acute facial nerve paralysis. Ultrasound has proved its ability in detecting structural lesions along the course of the affected nerves.The current work aimed at studying the accuracy of ultrasound to predict the prognosis of Bell palsy in correlation to the clinical scale and nerve conduction studies.

Methods: The study included 20 cases of acute Bell palsy treated with prednisolone and physiotherapy. The participants were examined using the House–Brackmann (HB) scale, electrophysiologically and neurosonologically in the affected side and healthy side that served as a control.

Results: There was significant correlation between HB outcomes with onset of HB results. There was significant increase in the distal facial nerve diameter on the affected side compared with the normal side (P < 0.001). Although ultrasound at onset did not predict the outcome, nerve conduction studies did predict the outcome.

Conclusions: Baseline HB clinical assessment of Bell palsy gives information on the clinical outcome of the disease. In addition to that, initial nerve conduction studies proved to be superior to ultrasound in predicting the outcome.

*Department of Neurology, Faculty of Medicine, Cairo University, Cairo, Egypt; and

Clinical Neurophysiology Unit, Faculty of Medicine, Cairo University, Cairo, Egypt.

Address correspondence and reprint requests to Alshaimaa Sobhi Khalil, MD, Clinical Neurophysiology Unit, Faculty of Medicine, Cairo University, 71 Kasr Al-Ainy St, 11562 Cairo, Egypt; e-mail: alshaimaa.sobhi@kasralainy.edu.eg.

The authors have no funding or conflicts of interest to disclose.

© 2018 by the American Clinical Neurophysiology Society